Published in Biochem J on January 01, 1996
Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J Clin Invest (1999) 2.32
Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. J Clin Invest (1996) 1.49
The interplay between size, morphology, stability, and functionality of high-density lipoprotein subclasses. Biochemistry (2008) 1.24
Serum opacity factor unmasks human plasma high-density lipoprotein instability via selective delipidation and apolipoprotein A-I desorption. Biochemistry (2007) 1.18
Disruption of human plasma high-density lipoproteins by streptococcal serum opacity factor requires labile apolipoprotein A-I. Biochemistry (2009) 1.05
Exchange of apolipoprotein A-I between lipid-associated and lipid-free states: a potential target for oxidative generation of dysfunctional high density lipoproteins. J Biol Chem (2010) 1.01
Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism. Biochim Biophys Acta (2011) 1.01
HDL-apoA-I exchange: rapid detection and association with atherosclerosis. PLoS One (2013) 0.86
Evaluation of phospholipid transfer protein and cholesteryl ester transfer protein as contributors to the generation of pre beta-high-density lipoproteins. Biochem J (2001) 0.86
Structural stability and functional remodeling of high-density lipoproteins. FEBS Lett (2015) 0.85
Plasma PLTP activity is inversely associated with HDL-C levels. Nutr Metab (Lond) (2009) 0.85
Spontaneous remodeling of HDL particles at acidic pH enhances their capacity to induce cholesterol efflux from human macrophage foam cells. J Lipid Res (2012) 0.84
Degradation of pyrene-labelled phospholipids by lysosomal phospholipases in vitro. Dependence of degradation on the length and position of the labelled and unlabelled acyl chains. Biochem J (1996) 0.83
Thermal transitions in serum amyloid A in solution and on the lipid: implications for structure and stability of acute-phase HDL. J Lipid Res (2015) 0.83
Impaired lipoprotein processing in HIV patients on antiretroviral therapy: aberrant high-density lipoprotein lipids, stability, and function. Arterioscler Thromb Vasc Biol (2013) 0.82
Apolipoprotein AI deficiency inhibits serum opacity factor activity against plasma high density lipoprotein via a stabilization mechanism. Biochemistry (2015) 0.82
In vivo effects of anacetrapib on preβ HDL: improvement in HDL remodeling without effects on cholesterol absorption. J Lipid Res (2013) 0.81
Impact of phospholipid transfer protein on nascent high-density lipoprotein formation and remodeling. Arterioscler Thromb Vasc Biol (2014) 0.80
Effects of cholesterol on thermal stability of discoidal high density lipoproteins. J Lipid Res (2009) 0.79
HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity. J Lipid Res (2015) 0.79
Formation of apolipoprotein-specific high-density lipoprotein particles from lipid-free apolipoproteins A-I and A-II. Biochem J (1999) 0.78
Setting the course for apoAII: a port in sight? Clin Lipidol (2013) 0.77
Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and Lipidomics. Cholesterol (2015) 0.77
Direct observation of lipoprotein cholesterol ester degradation in lysosomes. Biochem J (1998) 0.76
Fluorescent Sterols and Cholesteryl Esters as Probes for Intracellular Cholesterol Transport. Lipid Insights (2016) 0.75
Acylation of lysine residues in human plasma high density lipoprotein increases stability and plasma clearance in vivo. Biochim Biophys Acta (2016) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest (1955) 31.08
Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet (1975) 9.00
High-density lipoprotein--the clinical implications of recent studies. N Engl J Med (1989) 5.70
High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis (1989) 2.65
1-Palmitoyl-2-pyrenedecanoyl glycerophospholipids as membrane probes: evidence for regular distribution in liquid-crystalline phosphatidylcholine bilayers. Biochemistry (1985) 2.47
Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic. J Clin Invest (1983) 2.30
Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. Biochemistry (1988) 1.97
Characterization of human high-density lipoproteins by gradient gel electrophoresis. Biochim Biophys Acta (1981) 1.89
Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. Br Med J (Clin Res Ed) (1981) 1.80
Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II. J Biol Chem (1984) 1.70
Successful extrarenal transplantation from non-heart-beating donors. Transplantation (1995) 1.53
Complete cDNA encoding human phospholipid transfer protein from human endothelial cells. J Biol Chem (1994) 1.53
Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro. Proc Natl Acad Sci U S A (1978) 1.53
A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study. Arterioscler Thromb (1992) 1.45
Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem (1993) 1.43
Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. J Lipid Res (1988) 1.41
Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. J Biol Chem (1991) 1.39
In vitro modulation of the apolipoprotein composition of high density lipoprotein. Displacement of apolipoprotein A-I from high density lipoprotein by apolipoprotein A-II. J Biol Chem (1980) 1.33
Immunoturbidimetric determination of apolipoproteins A-1 and B in serum. Scand J Clin Lab Invest (1987) 1.20
High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J Biol Chem (1993) 1.13
Synthetic high density lipoprotein particles. Application to studies of the apoprotein specificity for selective uptake of cholesterol esters. J Biol Chem (1987) 1.11
Hydrolysis of human plasma high density lipoprotein 2- phospholipids and triglycerides by hepatic lipase. Biochem Biophys Res Commun (1981) 1.09
Apolipoprotein A-I-containing lipoproteins with pre-beta electrophoretic mobility. J Lipid Res (1985) 1.09
Role of apolipoproteins in cholesterol efflux from macrophages to lipid microemulsion: proposal of a putative model for the pre-beta high-density lipoprotein pathway. Biochemistry (1992) 1.07
A comparison of the surface activities of human apolipoproteins A-I and A-II at the air/water interface. Biochim Biophys Acta (1988) 1.04
Characterization of human high density lipoproteins by zonal ultracentrifugation. J Biol Chem (1980) 1.01
Thermal behavior of human plasma high density lipoprotein. Biochim Biophys Acta (1977) 1.01
Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL. Biochim Biophys Acta (1992) 0.99
Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance. Clin Chem (1992) 0.94
Transfer of [14C]phosphatidylcholine between liposomes and human plasma high density lipoprotein. Partial purification of a transfer-stimulating plasma factor using a rapid transfer assay. Biochim Biophys Acta (1982) 0.94
Role of apolipoproteins in cellular cholesterol efflux. Biochim Biophys Acta (1986) 0.90
Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma. Atherosclerosis (1991) 0.90
Kinetics and mechanism of the spontaneous transfer of fluorescent phosphatidylcholines between apolipoprotein-phospholipid recombinants. Biochemistry (1982) 0.89
Comparative study of phospholipid transfer activities mediated by cholesteryl ester transfer protein and phospholipid transfer protein. J Lipid Res (1994) 0.87
Role of lipid transfers in the formation of a subpopulation of small high density lipoproteins. J Lipid Res (1985) 0.87
Activation of human plasma lipid transfer protein by apolipoproteins. Biochemistry (1993) 0.85
The influence of apolipoproteins on the structure and function of spheroidal, reconstituted high density lipoproteins. J Biol Chem (1994) 0.84
Changes in the size and density of human high-density lipoproteins promoted by a plasma-conversion factor. Biochim Biophys Acta (1986) 0.83
Human apolipoprotein A-I liberated from high-density lipoprotein without denaturation. Biochemistry (1992) 0.82
Pig plasma phospholipid transfer protein facilitates HDL interconversion. J Lipid Res (1995) 0.82
Enhancement of the human plasma lipid transfer protein reaction by apolipoproteins. Biochim Biophys Acta (1991) 0.82
Biochemical characterization of the three major subclasses of lipoprotein A-I preparatively isolated from human plasma. Biochemistry (1993) 0.82
Selective transfer of cholesteryl ester over triglyceride by human plasma lipid transfer protein between apolipoprotein-activated lipid microemulsions. Biochemistry (1994) 0.81
Studies of the lipid binding characteristics of the apolipoproteins from human high density lipoprotein. II. Calorimetry of the binding of apo AI and apo AII with phospholipids. Biochim Biophys Acta (1976) 0.80
Cholesterol efflux from fibroblasts to discoidal lipoproteins with apolipoprotein A-I (LpA-I) increases with particle size but cholesterol transfer from LpA-I to lipoproteins decreases with size. Biochemistry (1993) 0.80
Transformations of reconstituted high-density lipoprotein subclasses as a function of temperature or LDL concentration. Biochim Biophys Acta (1991) 0.80
Isolation of a high-density-lipoprotein conversion factor from human plasma. A possible role of apolipoprotein A-IV as its activator. Biochem J (1988) 0.79
In vitro modulation of the distribution of normal human plasma high density lipoprotein subfractions through the lecithin: cholesterol acyltransferase reaction. Biochim Biophys Acta (1982) 0.79
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet (2005) 13.18
Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study. Diabetes Care (1998) 3.99
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology (1998) 2.83
Blood group M specific haemagglutinin in pyelonephritogenic Escherichia coli. Lancet (1982) 2.56
Quantitative determination of phospholipid compositions by ESI-MS: effects of acyl chain length, unsaturation, and lipid concentration on instrument response. J Lipid Res (2001) 1.92
Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci U S A (1999) 1.91
Lateral organization of liquid-crystalline cholesterol-dimyristoylphosphatidylcholine bilayers. Evidence for domains with hexagonal and centered rectangular cholesterol superlattices. Biochemistry (1995) 1.80
Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators. Hum Hered (1999) 1.76
Dissecting the role of the golgi complex and lipid rafts in biosynthetic transport of cholesterol to the cell surface. Proc Natl Acad Sci U S A (2000) 1.67
Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis (1991) 1.66
Serum complement and familial combined hyperlipidemia. Atherosclerosis (1997) 1.64
Elevated fasting plasma insulin in a general aged population: an innocent companion of cardiovascular diseases. J Am Geriatr Soc (1997) 1.59
Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia (2010) 1.53
Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23. Nat Genet (1998) 1.52
Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res (1986) 1.50
Effect of diet on serum lipoproteins in a population with a high risk of coronary heart disease. N Engl J Med (1982) 1.45
Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem (1993) 1.43
An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. Clin Chim Acta (1975) 1.43
The OSBP-related protein family in humans. J Lipid Res (2001) 1.40
Purification and characterization of lipoprotein lipase from pig adipose tissue. J Biol Chem (1974) 1.39
Multidisciplinary biopsychosocial rehabilitation for subacute low back pain in working-age adults: a systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine (Phila Pa 1976) (2001) 1.37
Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation (1995) 1.35
Multidisciplinary biopsychosocial rehabilitation for subacute low back pain among working age adults. Cochrane Database Syst Rev (2003) 1.34
Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet (1993) 1.34
Multidisciplinary biopsychosocial rehabilitation for neck and shoulder pain among working age adults. Cochrane Database Syst Rev (2003) 1.33
Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis (1994) 1.32
Characterization of two lipoproteins containing apolipoproteins B and E from lesion-free human aortic intima. J Lipid Res (1988) 1.31
The mechanism of the remodeling of high density lipoproteins by phospholipid transfer protein. J Biol Chem (2001) 1.30
The impact of phospholipid transfer protein (PLTP) on HDL metabolism. Atherosclerosis (2001) 1.29
Apolipoprotein E and B polymorphisms--longevity factors assessed in nonagenarians. Atherosclerosis (1994) 1.25
Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest (1987) 1.25
Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism. Diabetes (1977) 1.23
Multidisciplinary rehabilitation for fibromyalgia and musculoskeletal pain in working age adults. Cochrane Database Syst Rev (2000) 1.23
Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels. Am J Hum Genet (1999) 1.21
Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein. Atherosclerosis (1996) 1.20
Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice. Arterioscler Thromb Vasc Biol (2000) 1.20
Serum cholesterol concentration and mortality from accidents, suicide, and other violent causes. BMJ (1994) 1.18
The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences. Diabetes (2001) 1.17
Interaction of Munc-18-2 with syntaxin 3 controls the association of apical SNAREs in epithelial cells. J Cell Sci (1998) 1.16
Mass spectrometric analysis reveals an increase in plasma membrane polyunsaturated phospholipid species upon cellular cholesterol loading. Biochemistry (2001) 1.16
Phospholipid composition of the mammalian red cell membrane can be rationalized by a superlattice model. Proc Natl Acad Sci U S A (1998) 1.16
Human plasma lecithin-cholesterol acyltransferase. An elucidation of the catalytic mechanism. J Biol Chem (1986) 1.15
Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch Intern Med (1994) 1.15
Purification and quantitation of the human plasma lipoprotein carrying the Lp(a) antigen. Biochim Biophys Acta (1971) 1.14
PCR amplification of alleles at the DIS80 locus: comparison of a Finnish and a North American Caucasian population sample, and forensic casework evaluation. Am J Hum Genet (1992) 1.13
Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia. J Lipid Res (1989) 1.13
ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response. J Lipid Res (2001) 1.11
Membrane binding mechanism of an RNA virus-capping enzyme. J Biol Chem (2000) 1.11
Effect of moderate physical exercise on serum lipoproteins. A controlled clinical trial with special reference to serum high-density lipoproteins. Circulation (1979) 1.10
Membrane insertion and intracellular transport of yeast syntaxin Sso2p in mammalian cells. J Cell Sci (1994) 1.10
Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women. Circulation (2000) 1.10
Protein and carbohydrate composition of Lp(a)lipoprotein from human plasma. Biochemistry (1972) 1.09
Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet. Arteriosclerosis (1990) 1.08
Post-heparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridaemia: correlations to sex, age and various parameters of triglyceride metabolism. Clin Sci Mol Med (1976) 1.07
A search strategy for occupational health intervention studies. Occup Environ Med (2005) 1.07
Application of DNA "fingerprints" to paternity determinations. Lancet (1988) 1.07
Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project. Atherosclerosis (2000) 1.06
Preparation, characterization, and measurement of hepatic lipase. Methods Enzymol (1986) 1.06
The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns. J Clin Invest (1996) 1.06
A sec1-related vesicle-transport protein that is expressed predominantly in epithelial cells. Eur J Biochem (1996) 1.06
Heterogeneity of primary lipoprotein lipase deficiency. Metabolism (1980) 1.05
The OSBP-related proteins (ORPs): global sterol sensors for co-ordination of cellular lipid metabolism, membrane trafficking and signalling processes? Biochem Soc Trans (2006) 1.04
Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women. Atherosclerosis (1995) 1.04
The hypercholesterolaemic factor in boiled coffee is retained by a paper filter. J Intern Med (1991) 1.04
Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia. Proc Natl Acad Sci U S A (1984) 1.03
Transversal distribution of acyl-linked pyrene moieties in liquid-crystalline phosphatidylcholine bilayers. A fluorescence quenching study. Biochemistry (1995) 1.02
gamma-cyclodextrins greatly enhance translocation of hydrophobic fluorescent phospholipids from vesicles to cells in culture. Importance of molecular hydrophobicity in phospholipid trafficking studies. J Biol Chem (1999) 1.02
Changes in serum lipids, lipoproteins, and heparin releasable lipolytic enzymes during moderate physical training in man: a longitudinal study. Metabolism (1981) 1.01
Studies on the defect underlying the lysosomal storage of sialic acid in Salla disease. Lysosomal accumulation of sialic acid formed from N-acetyl-mannosamine or derived from low density lipoprotein in cultured mutant fibroblasts. J Clin Invest (1986) 1.01
Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes. Diabetologia (2010) 1.01
Evidence for superlattice arrangements in fluid phosphatidylcholine/phosphatidylethanolamine bilayers. Biophys J (1997) 1.01
Serum ferritin and ceruloplasmin as coronary risk factors. Eur Heart J (1994) 1.00
Single nucleotide polymorphisms in exons of the apo(a) kringles IV types 6 to 10 domain affect Lp(a) plasma concentrations and have different patterns in Africans and Caucasians. Hum Mol Genet (2001) 1.00
Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am J Cardiol (1985) 0.99
Stearic acid, trans fatty acids, and dairy fat: effects on serum and lipoprotein lipids, apolipoproteins, lipoprotein(a), and lipid transfer proteins in healthy subjects. Am J Clin Nutr (1997) 0.99
Dipyrenylphosphatidylcholines as membrane fluidity probes. Relationship between intramolecular and intermolecular excimer formation rates. Biophys J (1990) 0.98
Purification and characterization of lipoprotein lipase from pig myocardium. Biochem J (1975) 0.98
High-density lipoproteins can act as carriers of glycophosphoinositol lipid-anchored CD59 in human plasma. Immunology (1994) 0.97
Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL. Biochim Biophys Acta (1996) 0.97
Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study. J Lipid Res (1990) 0.97
Purification from human plasma of a heparin-released lipase with activity against triglyceride and phospholipids. J Biol Chem (1975) 0.97
Distribution of phospholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive. J Lipid Res (2000) 0.96
Fluorescence studies of dehydroergosterol in phosphatidylethanolamine/phosphatidylcholine bilayers. Biophys J (1999) 0.96
Triglyceride-enrichment of high density lipoproteins enhances their remodelling by phospholipid transfer protein. J Lipid Res (1998) 0.96
Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients. Arteriosclerosis (1989) 0.96
Manual material handling advice and assistive devices for preventing and treating back pain in workers. Cochrane Database Syst Rev (2007) 0.96